ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

HHS Draft of Bill Reauthorizing NIH Specifically Kills Bypass Budget, Would End National Cancer Act of 1971

March 29, 1985

Judge Hears Arguments In Fisher’s Privacy Act Suit Over Databases

January 19, 1996

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981

New Publications

January 20, 1989

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976